Assessment of therapeutic strategies in unipolar depression with incomplete response to a antidepressant treatment in regular clinical practicing.
Major depressive disorder
18 Years - 65 Years
Endpoint Classification: -
Intervention Model: -
Primary Purpose: -
Verified 01 Dec 2009 by AstraZeneca Pharmaceuticals
No locations available
Outpatient with major depressive disorder, who has a change in pharmacological therapeutical plan after an incomplete response or intolerance to a treatment with an adequate dosage of an antidepressant (SSRI/NSRI) (20-40 mg fluoxetine, 75-225 mg venlafaxine or equivalent) for at least 6 weeks.